Publication | Closed Access

Dual targeting of mTORC1/C2 complexes enhances histone deacetylase inhibitor-mediated anti-tumor efficacy in primary HCC cancer in vitro and in vivo

OncologyMtorc1/c2 ComplexesMedicinePrimary Hcc CancerPharmacologyDual TargetingAnti-cancer AgentCancer TreatmentCancer BiologyCell BiologyCancer ResearchTumor Biology